TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1257366

Group type: EXPERIMENTAL
Intervention: Cannabis cigarettes delivering 7 mg delta9-THC; administered during four training sessions and tested in the drug condition.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-drug condition; subjects trained without cannabis.
Number of subjects: 0
Study: 31976814

Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5-10 mg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) (12.5-25 mg/day)
Number of subjects: 60
Study: 30659611

Group type: EXPERIMENTAL
Intervention: INP104 1.45 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: IV DHE 1.0 mg
Number of subjects: 38

Group type: COMPARATOR
Intervention: Migranal 2.0 mg
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: INP104
Number of subjects: 38

Group type: COMPARATOR
Intervention: IV DHE
Number of subjects: 38

Group type: COMPARATOR
Intervention: Migranal
Number of subjects: 38
Study: 26095948

Group type: EXPERIMENTAL
Intervention: Rotigotine (titrated over 1-7 weeks to optimal dose ≤8 mg/24 h for patients not receiving levodopa, ≤16 mg/24 h for patients receiving levodopa)
Number of subjects: 349

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349

Group type: EXPERIMENTAL
Intervention: Rotigotine
Number of subjects: 349
Study: 23615091

Group type: EXPERIMENTAL
Intervention: Auditory naming
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Visual naming
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Sentence completion
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Visual and auditory naming
Number of subjects: 28
Study: 20798922

Group type: EXPERIMENTAL
Intervention: Polypropylene mesh
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cadaveric fascia lata
Number of subjects: 100
Study: 18060659

Group type: EXPERIMENTAL
Intervention: Weight reduction (per 1 kg/year) in IFG individuals
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Decreased triacylglycerol (per 1 mmol l(‐1) year(‐1)) in IFG individuals
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Weight reduction (per 1 kg/year) in IGT individuals
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Baseline glucose measures in IFG individuals
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: BMI (per kg/m2) in IFG individuals
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Known hypertension in IGT individuals
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Progression rates from IFG to diabetes
Number of subjects: 1818

Group type: EXPERIMENTAL
Intervention: Progression rates from IGT to diabetes
Number of subjects: 1818
Study: 16084584

Group type: EXPERIMENTAL
Intervention: Flowable compomer
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Flowable composite
Number of subjects: 30

Group type: COMPARATOR
Intervention: Compomer restoration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Composite E
Number of subjects: 30

Group type: COMPARATOR
Intervention: Composite RF
Number of subjects: 30
Study: 12887362

Group type: EXPERIMENTAL
Intervention: Device group (device plus pamphlet)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (pamphlet only)
Number of subjects: 46
Study: 10850898

Group type: EXPERIMENTAL
Intervention: Massage therapy (30-minute massage with cocoa butter, twice a week for 5 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard treatment control
Number of subjects: 20
Study: 8612828

Group type: EXPERIMENTAL
Intervention: Computer-assisted analysis
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Trained andrologists
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Updated software for computer analysis
Number of subjects: 24
Study: 1385972

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 6149965

Group type: EXPERIMENTAL
Intervention: BW 825C (4 mg)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: BW 825C (8 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30738171

Group type: EXPERIMENTAL
Intervention: GBR 830 (10 mg/kg intravenous on day 1 and day 29)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: GBR 830
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 30578205

Group type: EXPERIMENTAL
Intervention: Mobile game group (n=36)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (n=40)
Number of subjects: 76
Study: 27026087

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) applied in the cervicothoracic region for 30 days.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Sham group (no stimulation).
Number of subjects: 56
Study: 24479760

Group type: EXPERIMENTAL
Intervention: Tai Chi-based exercise program via telerehabilitation (45-minute session twice a week for eight consecutive weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tai Chi-based exercise program provided in person at home (45-minute session twice a week for eight consecutive weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tai Chi-based exercise program via telerehabilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tai Chi-based exercise program provided in person at home
Number of subjects: 0
Study: 22403695

Group type: EXPERIMENTAL
Intervention: YouRAction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: YouRAction+e
Number of subjects: 0

Group type: COMPARATOR
Intervention: Generic Information (GI)
Number of subjects: 0
Study: 21143077

Group type: EXPERIMENTAL
Intervention: Inhaling hot dry air in a sauna
Number of subjects: 157

Group type: COMPARATOR
Intervention: Dry air at room temperature in a sauna
Number of subjects: 157
Study: 17545089

Group type: EXPERIMENTAL
Intervention: Prednisone plus Ginkgo biloba leaf extract
Number of subjects: 35

Group type: COMPARATOR
Intervention: Prednisone plus dipyridamole
Number of subjects: 35
Study: 15932638

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium infusion (GIK)
Number of subjects: 940

Group type: COMPARATOR
Intervention: Control (no infusion)
Number of subjects: 940
Study: 12498758

Group type: EXPERIMENTAL
Intervention: Scan-specific calculated attenuation correction (CAC)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Default measured attenuation correction (MAC)
Number of subjects: 0
Study: 9653487

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8573430

Group type: EXPERIMENTAL
Intervention: Tiludronate therapy for 3 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tiludronate therapy for 2 years (non-fracture studies)
Number of subjects: 0
Study: 2092187

Group type: EXPERIMENTAL
Intervention: Nimesulide (400 mg/die, 2 suppositories per day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Flurbiprofen (200 mg/die, 2 suppositories per day)
Number of subjects: 40
Study: 392743

Group type: EXPERIMENTAL
Intervention: Myc 2095 (20 mg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: triamcinolone hexacetonide (20 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31903712

Group type: EXPERIMENTAL
Intervention: Exenatide (EXE) once weekly (2 mg/wk subcutaneously)
Number of subjects: 32
Study: 31119179

Group type: EXPERIMENTAL
Intervention: Nordic Walking (NW) training for 10 weeks, 3 times a week
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group with no specific intervention
Number of subjects: 22
Study: 29256337

Group type: EXPERIMENTAL
Intervention: 16-week self-management intervention consisting of group meetings, individual counseling, and a book
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group receiving information about active lifestyle through one group meeting and a book
Number of subjects: 64
Study: 25179153

Group type: EXPERIMENTAL
Intervention: 500 µg nitroglycerin
Number of subjects: 1706

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1706
Study: 23932910

Group type: EXPERIMENTAL
Intervention: Implicit Association Test (IAT)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Self-report measures
Number of subjects: 73
Study: 22545357

Group type: EXPERIMENTAL
Intervention: Ginger
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metoclopramide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19860883

Group type: EXPERIMENTAL
Intervention: 1 ml of triamcinolonacetonide (TCA)
Number of subjects: 21

Group type: COMPARATOR
Intervention: NaCl 0.9% (placebo)
Number of subjects: 21
Study: 17090280

Group type: EXPERIMENTAL
Intervention: Small-caliber upper endoscope (9.2 mm)
Number of subjects: 244
Study: 14975474

Group type: EXPERIMENTAL
Intervention: Combined vitamin E (800 IU per day) and C (1000 mg per day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Combined vitamin E and C
Number of subjects: 30
Study: 11329998

Group type: EXPERIMENTAL
Intervention: Mental health treatment
Number of subjects: 1920

Group type: EXPERIMENTAL
Intervention: Substance abuse treatment
Number of subjects: 1920

Group type: EXPERIMENTAL
Intervention: Treatment for anxiety and depression
Number of subjects: 1920

Group type: EXPERIMENTAL
Intervention: Substance abuse symptoms
Number of subjects: 1920
Study: 9221995

Group type: EXPERIMENTAL
Intervention: Heparin and aspirin
Number of subjects: 191

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 191
Study: 8073693

Group type: EXPERIMENTAL
Intervention: M‐1 daily in a dose of 15‐50 g, fish oil in a dose of 10‐30 ml
Number of subjects: 142

Group type: COMPARATOR
Intervention: Control subjects (no diet)
Number of subjects: 142
Study: 3103989

Group type: EXPERIMENTAL
Intervention: Metered Dose Inhaler (MDI)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Up‐draft Nebulization (UDN)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Both MDI and UDN
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Routine use of MDI
Number of subjects: 34
Study: 31948641

Group type: EXPERIMENTAL
Intervention: Alirocumab
Number of subjects: 18924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18924
Study: 29303469

Group type: EXPERIMENTAL
Intervention: Percutaneous transforaminal endoscopic discectomy (PTED)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Microendoscopic discectomy (MED)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: PTED
Number of subjects: 153

Group type: COMPARATOR
Intervention: MED
Number of subjects: 153
Study: 28858279

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment with bracket-systems and dental foam (Splat, Russia) after meal (Group 3)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Orthodontic treatment with bracket-systems (Group 2)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Control group with no orthodontic treatment (n=35)
Number of subjects: 106
Study: 24077380

Group type: EXPERIMENTAL
Intervention: Static stretching condition (SC)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control condition (CC)
Number of subjects: 15
Study: 23021093

Group type: EXPERIMENTAL
Intervention: Ranibizumab 0.5 mg
Number of subjects: 234
Study: 20725117

Group type: EXPERIMENTAL
Intervention: Creatine monohydrate (25 g.day(‐1) for 5 days, followed by 5 g.day(‐1) for 3 days)
Number of subjects: 40
Study: 18670219

Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg daily for 3 days)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 15957564

Group type: EXPERIMENTAL
Intervention: Assigned a roommate who binge drank in high school
Number of subjects: 714

Group type: COMPARATOR
Intervention: Assigned a nonbinge-drinking roommate
Number of subjects: 714

Group type: EXPERIMENTAL
Intervention: Students who did not engage in these behaviors in high school
Number of subjects: 714
Study: 12618570

Group type: EXPERIMENTAL
Intervention: Experimental arm receiving a workbook and a series of six 4-page newsletters delivered every 7 weeks, tailored to individual characteristics
Number of subjects: 530

Group type: COMPARATOR
Intervention: Control arm receiving a series of nontailored health brochures
Number of subjects: 530
Study: 10498145

Group type: EXPERIMENTAL
Intervention: Abciximab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no abciximab)
Number of subjects: 0
Study: 7861015

Group type: EXPERIMENTAL
Intervention: Stavudine (daily doses ranging from 0.1 to 12.0 mg/kg)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Stavudine (doses of < or = 2 mg/kg/day, n = 216)
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Stavudine
Number of subjects: 259
Study: 1952200

Group type: EXPERIMENTAL
Intervention: Isoflurane (0.5 MAC inspired concentration)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Halothane (0.5 MAC inspired concentration)
Number of subjects: 40
Study: 6894241

Group type: EXPERIMENTAL
Intervention: 375 mg azidocillin tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 750 mg azidocillin tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 1500 mg azidocillin tablets
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 750 mg azidocillin suspension
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 799 mg azidocillin i.m. injection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 750 mg azidocillin tablets twice daily for 14 days
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 750 mg azidocillin i.v. dosage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: i.m. azidocillin dose
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: i.v. azidocillin doses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: other dosage forms of azidocillin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: i.v. administration of azidocillin
Number of subjects: 0
Study: 31314208

Group type: EXPERIMENTAL
Intervention: Educational strategy (I prefer plain water)
Number of subjects: 777

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 777
Study: 28811737

Group type: EXPERIMENTAL
Intervention: Faith-based intervention
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Secular intervention
Number of subjects: 469

Group type: COMPARATOR
Intervention: Self-guided control group
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Pedometer-assessed daily steps
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Accelerometer-assessed minutes of daily moderate-to-vigorous PA
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Self-reported minutes of weekly walking and moderate- and vigorous-intensity PA
Number of subjects: 469
Study: 25782408

Group type: EXPERIMENTAL
Intervention: Generic clopidogrel besylate (CB)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Innovator clopidogrel hydrogen sulphate (CHS)
Number of subjects: 1800
Study: 23696818

Group type: EXPERIMENTAL
Intervention: Ratio measure of health inequality
Number of subjects: 40

Group type: COMPARATOR
Intervention: Difference measure of health inequality
Number of subjects: 40
Study: 21211558

Group type: EXPERIMENTAL
Intervention: Bitter melon 2,000 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metformin 1,000 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bitter melon 500 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bitter melon 1,000 mg/day
Number of subjects: 0
Study: 18437414

Group type: EXPERIMENTAL
Intervention: One-back choice RT task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response-stimulus interval of the one-back task
Number of subjects: 0
Study: 16842799

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens 0.625 mg (CEE)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 17beta-estradiol 1mg plus norethisterone acetate 0.5mg (E(2)/NETA)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Raloxifene HCl 60 mg
Number of subjects: 88

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 88
Study: 15285981

Group type: EXPERIMENTAL
Intervention: Increased awareness of psychiatric condition at baseline
Number of subjects: 980

Group type: EXPERIMENTAL
Intervention: Changes in awareness associated with treatment
Number of subjects: 980
Study: 11300390

Group type: EXPERIMENTAL
Intervention: Neostigmine (50 microg kg(-1)) and glycopyrrolate (10 microg kg(-1))
Number of subjects: 90

Group type: COMPARATOR
Intervention: NaCl i.v. as placebo
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 90
Study: 9397292

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30-120 mg/day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Enalapril 5-30 mg/day
Number of subjects: 46
Study: 7949259

Group type: COMPARATOR
Intervention: CA 19-9
Number of subjects: 171

Group type: COMPARATOR
Intervention: CA 50
Number of subjects: 171
Study: 2905724

Group type: EXPERIMENTAL
Intervention: Temocillin
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control (no antibiotic cover)
Number of subjects: 308
Study: 30010353

Group type: EXPERIMENTAL
Intervention: Tension Tamer (TT) guided BAM sessions for 5-min intervals twice daily
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tension Tamer (TT) guided BAM sessions for 10-min intervals twice daily
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Tension Tamer (TT) guided BAM sessions for 15-min intervals twice daily
Number of subjects: 64
Study: 28768474

Group type: EXPERIMENTAL
Intervention: 200 mg vaginal progesterone
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Progesterone treatment (meta-analysis)
Number of subjects: 41
Study: 26220020

Group type: EXPERIMENTAL
Intervention: Yoga program for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no yoga exercise)
Number of subjects: 0
Study: 24124750

Group type: EXPERIMENTAL
Intervention: Laparoscopic extralevator abdominoperineal excision (LELAPE)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Laparoscopic abdominoperineal excision (LAPE)
Number of subjects: 35
Study: 20624257

Group type: EXPERIMENTAL
Intervention: Intravenous iron (200 mg of iron sucrose) and recombinant human erythropoietin‐β (3000 IU)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (Group C)
Number of subjects: 108
Study: 19057246

Group type: EXPERIMENTAL
Intervention: IP‐CHA spacers
Number of subjects: 88

Group type: COMPARATOR
Intervention: Autogenous bone spacers
Number of subjects: 88
Study: 16466883

Group type: EXPERIMENTAL
Intervention: Behçet's disease with ocular involvement
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Behçet's disease without ocular involvement
Number of subjects: 51

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 51
Study: 14714012

Group type: EXPERIMENTAL
Intervention: RBC 400 mg, clarithromycin 250 mg and metronidazole 500 mg regimen, all drugs given twice daily for 7 days
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Enhanced regimen with RBC, clarithromycin and metronidazole
Number of subjects: 146
Study: 10933004

Group type: EXPERIMENTAL
Intervention: Gel materials
Number of subjects: 4

Group type: COMPARATOR
Intervention: Foam materials
Number of subjects: 4
Study: 8780106

Group type: EXPERIMENTAL
Intervention: Immunosuppressive treatment (prednisolone plus azathioprine)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1344473

Group type: EXPERIMENTAL
Intervention: Nizatidine 150 mg twice daily
Number of subjects: 120

Group type: COMPARATOR
Intervention: Ranitidine (control) twice daily
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Nizatidine 300 mg once daily
Number of subjects: 120
Study: 6421560

Group type: EXPERIMENTAL
Intervention: Combined regimen of insulin and sulphonylurea (glibenclamide) for ten days, followed by ten days of insulin alone, followed by six months of combined treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Insulin alone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Renewed combined treatment with sulphonylurea and insulin
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combined treatment with sulphonylurea and insulin
Number of subjects: 16
Study: 31490254

Group type: EXPERIMENTAL
Intervention: 80% inspired intraoperative oxygen
Number of subjects: 4481

Group type: COMPARATOR
Intervention: 30% inspired intraoperative oxygen
Number of subjects: 4481
Study: 31103101

Group type: EXPERIMENTAL
Intervention: IASTM
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Stretching
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 28683243

Group type: EXPERIMENTAL
Intervention: 15 grams of protein distributed across 2 isoenergetic carbohydrate-containing beverages (15 and 240 min postexercise) with varying amounts of protein (0 + 15 g, 5 + 10 g, 10 + 5 g, and 15 + 0 g)
Number of subjects: 35
Study: 26451374

Group type: EXPERIMENTAL
Intervention: 12‐hour exposure in a normobaric hypoxic chamber
Number of subjects: 37
Study: 23932244

Group type: EXPERIMENTAL
Intervention: Yoga therapy (60-min sessions weekly for 8 weeks)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (weekly regular day-care program)
Number of subjects: 49
Study: 21897841

Group type: EXPERIMENTAL
Intervention: Manual-based group intervention
Number of subjects: 81

Group type: COMPARATOR
Intervention: Leaflet control condition
Number of subjects: 81
Study: 20043564

Group type: EXPERIMENTAL
Intervention: Rectum cleaning with 10% povidone-iodine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no rectum cleaning)
Number of subjects: 100
Study: 17764454

Group type: EXPERIMENTAL
Intervention: Self-help leaflet (moderate group)
Number of subjects: 1175

Group type: EXPERIMENTAL
Intervention: Structured help from a continence nurse (severe group)
Number of subjects: 1175

Group type: COMPARATOR
Intervention: No intervention (mild group)
Number of subjects: 1175

Group type: COMPARATOR
Intervention: No intervention (moderate group)
Number of subjects: 1175
Study: 15071842

Group type: EXPERIMENTAL
Intervention: Nootropil 70 mg/kg daily
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nootropil 40 mg/kg daily
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 80
Study: 11408983

Group type: EXPERIMENTAL
Intervention: Topical phenytoin sodium
Number of subjects: 47

Group type: COMPARATOR
Intervention: DuoDerm dressings
Number of subjects: 47

Group type: COMPARATOR
Intervention: Triple antibiotic ointment
Number of subjects: 47
Study: 9505252

Group type: EXPERIMENTAL
Intervention: Artificial Neural Networks (ANN) classification
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Minimal net with three variables (peak VO2 at high velocity, hand force on the rim at low velocity, push angle at high velocity)
Number of subjects: 15